We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Synchrony's (SYF) CareCredit Offers Pet Care Financing Option
Read MoreHide Full Article
Synchrony Financial (SYF - Free Report) recently announced its partnership with the University of Missouri, Oregon State University and Virginia Tech to offer financing options for pet care in the schools’ veterinary university hospitals. The tie-up will pave the way for SYF’s CareCredit health and wellness credit card and offer pet financing solutions in more than 95% of veterinary university hospitals nationwide. The company’s shares gained 1.5% on Sept 14.
This move bodes well for Synchrony Financial, as wider adoption of CareCredit is expected to boost the top line in the future. With SYF’s CareCredit expansion, it is evident that the company is focused on expanding the business with attention paid to health systems. Health and Wellness accounted for 16% of the total interest and fees on loans of SYF in the second quarter of 2023. This move will also lead to increased contributions from this segment and a rise in the loan receivables portfolio, paving the way for higher interest income and fees on loans. The company expects loan receivables growth of more than 10% in 2023.
Synchrony Financial’s CareCredit will provide flexible financial solutions to pet owners and educate veterinarians about mental health and wellness techniques, management of finances, financial literacy, etc. Pet parents can check if they prequalify for a CareCredit credit card without impacting their credit score in real time. They can apply on any smart device or over their phone. Once approved, pet parents can make the payment immediately. Short-term and long-term promotional financing options will be available depending on the purchase amount.
Partnerships similar to the latest one are expected to boost the presence of CareCredit across the pet care space. Expanding the reach of CareCredit financing solutions also bolsters the purchasing power of consumers and reduces hurdles for patients in availing of quality health care. SYF pursues uninterrupted efforts to offer advanced credit products best suited to address evolving customer expectations and serve diversified industries.
Shares of Synchrony Financial gained 10.7% in the past six months compared with the industry’s 4.7% rise. SYF currently carries a Zacks Rank #3 (Hold).
The bottom line of Fidus Investment outpaced estimates in each of the last four quarters, the average surprise being 9.5%. The Zacks Consensus Estimate for FDUS’s 2023 earnings and revenues suggests an improvement of 30.3% and 35.4%, respectively, from the year-ago reported figures. The consensus mark for FDUS’s 2023 earnings has moved 5.6% north in the past 60 days.
BlackRock Capital’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 12.9%. The Zacks Consensus Estimate for BKCC’s 2023 earnings and revenues suggests an improvement of 20% and 37.8%, respectively, from the year-ago reported figures. The consensus mark for BKCC’s 2023 earnings has moved 4.3% north in the past 60 days.
The bottom line of Americold Realty outpaced estimates in three of the last four quarters and matched the mark once, the average surprise being 8.81%. The Zacks Consensus Estimate for COLD’s 2023 earnings suggests an improvement of 13.5% from the year-ago reported figure. The consensus mark for COLD's 2023 earnings has moved 4.1% north in the past 30 days.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Synchrony's (SYF) CareCredit Offers Pet Care Financing Option
Synchrony Financial (SYF - Free Report) recently announced its partnership with the University of Missouri, Oregon State University and Virginia Tech to offer financing options for pet care in the schools’ veterinary university hospitals. The tie-up will pave the way for SYF’s CareCredit health and wellness credit card and offer pet financing solutions in more than 95% of veterinary university hospitals nationwide. The company’s shares gained 1.5% on Sept 14.
This move bodes well for Synchrony Financial, as wider adoption of CareCredit is expected to boost the top line in the future. With SYF’s CareCredit expansion, it is evident that the company is focused on expanding the business with attention paid to health systems. Health and Wellness accounted for 16% of the total interest and fees on loans of SYF in the second quarter of 2023. This move will also lead to increased contributions from this segment and a rise in the loan receivables portfolio, paving the way for higher interest income and fees on loans. The company expects loan receivables growth of more than 10% in 2023.
Synchrony Financial’s CareCredit will provide flexible financial solutions to pet owners and educate veterinarians about mental health and wellness techniques, management of finances, financial literacy, etc. Pet parents can check if they prequalify for a CareCredit credit card without impacting their credit score in real time. They can apply on any smart device or over their phone. Once approved, pet parents can make the payment immediately. Short-term and long-term promotional financing options will be available depending on the purchase amount.
Partnerships similar to the latest one are expected to boost the presence of CareCredit across the pet care space. Expanding the reach of CareCredit financing solutions also bolsters the purchasing power of consumers and reduces hurdles for patients in availing of quality health care. SYF pursues uninterrupted efforts to offer advanced credit products best suited to address evolving customer expectations and serve diversified industries.
Shares of Synchrony Financial gained 10.7% in the past six months compared with the industry’s 4.7% rise. SYF currently carries a Zacks Rank #3 (Hold).
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks in the Finance space are Fidus Investment Corporation (FDUS - Free Report) , BlackRock Capital Investment Corporation and Americold Realty Trust, Inc. (COLD - Free Report) . Each of these companies presently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The bottom line of Fidus Investment outpaced estimates in each of the last four quarters, the average surprise being 9.5%. The Zacks Consensus Estimate for FDUS’s 2023 earnings and revenues suggests an improvement of 30.3% and 35.4%, respectively, from the year-ago reported figures. The consensus mark for FDUS’s 2023 earnings has moved 5.6% north in the past 60 days.
BlackRock Capital’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 12.9%. The Zacks Consensus Estimate for BKCC’s 2023 earnings and revenues suggests an improvement of 20% and 37.8%, respectively, from the year-ago reported figures. The consensus mark for BKCC’s 2023 earnings has moved 4.3% north in the past 60 days.
The bottom line of Americold Realty outpaced estimates in three of the last four quarters and matched the mark once, the average surprise being 8.81%. The Zacks Consensus Estimate for COLD’s 2023 earnings suggests an improvement of 13.5% from the year-ago reported figure. The consensus mark for COLD's 2023 earnings has moved 4.1% north in the past 30 days.